Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Eri

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 10, 1986
[Primary hyperparathyroidism. Surgical case material from Aker Hospital 1974-85]L M Eri, S Sander
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 1985
[Adenocarcinoma of the colon and rectum. A population study]L M Eri, R Hoel
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 28, 1987
[Surgical treatment of the impingement syndrome]L M Eri, E Gjengedal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 30, 1988
[Urethral diverticulum in women]L M Eri, B Klevmark
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1987
[Subtotal cholecystectomy. An alternative to a difficult cholecystectomy]L M Eri, I Liavåg
Urology|August 5, 2000
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?L M Eri, A Svindland
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 30, 1988
[Primary megaureter in adults]L M Eri, B Klevmark
European Urology|January 1, 1995
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasiaL M Eri, P Urdal
Prostate Cancer and Prostatic Diseases|December 24, 2002
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)L M Eri, K J Tveter
European Urology|January 1, 1994
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasiaL M Eri, K J Tveter
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 10, 1986
[Primary hyperparathyroidism. Surgical case material from Aker Hospital 1974-85]L M Eri, S Sander
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 1985
[Adenocarcinoma of the colon and rectum. A population study]L M Eri, R Hoel
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 28, 1987
[Surgical treatment of the impingement syndrome]L M Eri, E Gjengedal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 30, 1988
[Urethral diverticulum in women]L M Eri, B Klevmark
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1987
[Subtotal cholecystectomy. An alternative to a difficult cholecystectomy]L M Eri, I Liavåg
Urology|August 5, 2000
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?L M Eri, A Svindland
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 30, 1988
[Primary megaureter in adults]L M Eri, B Klevmark
European Urology|January 1, 1995
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasiaL M Eri, P Urdal
Prostate Cancer and Prostatic Diseases|December 24, 2002
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)L M Eri, K J Tveter
European Urology|January 1, 1994
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasiaL M Eri, K J Tveter
Pageof 4